Volume 41, Issue 2, Pages (August 2004)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
S. Shaikh, J. Brittenden, R. Lahiri, P. A. J. Brown, F. Thies, H. M
Volume 66, Issue 4, Pages (April 2017)
Volume 67, Issue 2, Pages (August 2017)
Volume 46, Issue 3, Pages (March 2007)
Volume 144, Issue 1, Pages 7-14 (May 1999)
Volume 59, Issue 2, Pages (February 2011)
Inflammasomes in liver diseases
Angiogenesis and hepatocellular carcinoma
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 38, Issue 1, Pages 9-17 (January 2003)
Volume 125, Issue 4, Pages (October 2003)
L. Nikitina, F. Wenger, M. Baumann, D. Surbek, M. Körner, C. Albrecht 
Volume 51, Issue 3, Pages (September 2009)
Volume 54, Issue 2, Pages (August 1998)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 41, Issue 2, Pages (August 2004)
Volume 54, Issue 6, Pages (January 1998)
NS5A inhibitors in the treatment of hepatitis C
Hassane Izzedine, MD, PhD, Philippe Rouvier, MD, Gilbert Deray, MD 
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Gastroesophageal tumor embolization to the popliteal arteries
Volume 55, Issue 1, Pages (July 2011)
Volume 44, Issue 2, Pages (February 2006)
Central venous catheter failure is induced by injury and can be prevented by stabilizing the catheter tip  Ted R. Kohler, MD, Thomas R. Kirkman, BS  Journal.
Volume 67, Issue 2, Pages (August 2017)
Molecular Therapy - Nucleic Acids
Regulatory T-cell directed therapies in liver diseases
Volume 42, Issue 5, Pages (May 2005)
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.
The place of downstaging for hepatocellular carcinoma
Adult hepatoblastoma: Learning from children
Familial amyloid polyneuropathy and liver transplantation
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients  C. Deligne, S. Casulli,
Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab  Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD 
Overexpression of transforming growth factor–β1 correlates with increased synthesis of nitric oxide synthase in varicose veins  Theresa Jacob, PhD, Anil.
Volume 72, Issue 6, Pages (September 2007)
Angiogenesis and hepatocellular carcinoma
Integrin Alpha 6: Anchors Away for Glioma Stem Cells
An Uncommon Cause of Membranous Glomerulonephritis
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Capillary hemangioma of the testis
Volume 39, Issue 4, Pages (October 2003)
Volume 77, Issue 9, Pages (May 2010)
HCMV jogs the ‘memory’ of NK cells in HBV
Expression Pattern of Wnt Signaling Components in the Adult Intestine
Deposition of Complement Product C4d in Anti–Glomerular Basement Membrane Glomerulonephritis  Ibrahim Batal, MD, Geetha Chalasani, MD, Christine Wu, MD,
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again…
Molecular prognostication of liver cancer: End of the beginning
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Volume 125, Issue 4, Pages (October 2003)
Chetana Lim, Chady Salloum, Daniel Azoulay
Evolution of liver transplantation for hepatocellular carcinoma
The identification of small nodules in liver adenomatosis
Volume 42, Issue 6, Pages (June 2005)
Volume 39, Issue 2, Pages (August 2003)
Thrombus-free, human endothelial surface in the midregion of a Dacron vascular graft in the splanchnic venous circuit—Observations after nine months of.
Pathogenesis of cholestatic hepatitis C
Volume 58, Issue 4, Pages (April 2013)
Genetics of hepatocellular carcinoma: The next generation
Volume 53, Issue 1, Pages (July 2010)
Volume 67, Issue 5, Pages (November 2017)
Molecular Therapy - Nucleic Acids
Tissue proteomics: a new investigative tool for renal biopsy analysis
Woo-Yong Lee, Paul Kubes  Journal of Hepatology 
Presentation transcript:

Volume 41, Issue 2, Pages 259-266 (August 2004) Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis  Géraldine Gouysse, Sophie Frachon, Valérie Hervieu, Michelangelo Fiorentino, Antonia d'Errico, Jérôme Dumortier, Olivier Boillot, Christian Partensky, Walter F. Grigioni, Jean-Yves Scoazec  Journal of Hepatology  Volume 41, Issue 2, Pages 259-266 (August 2004) DOI: 10.1016/j.jhep.2004.04.014

Fig. 1 Sinusoidal pattern of endothelial cell differentiation in hepatocellular adenoma CD31 (a) is strongly expressed by the endothelial lining of an intra-tumoral artery and its adjacent vessels (long arrows); its expression along intra-tumoral vessels (large arrow) is not detectable. CD34 (b) is restricted to a few peri-arterial capillary vessels (long arrows) and is undetectable along intra-tumoral sinusoid vessels (large arrow). CD4 (c) and the receptor II for FcIgG (Cdw32) (d) are readily detectable all along intra-tumoral sinusoid vessels (arrows). Laminin-1 (e) is readily detected in the subendothelial matrix of an intra-tumoral artery (large arrow); faint deposits are also visible along intra-tumoral sinusoid vessels (thin arrows). Tenascin (f) is abundant in the subendothelial matrix of intra-tumoral sinusoid vessels (thin arrow). (Frozen tissue sections; immunoperoxidase followed by Mayer's hematoxylin, original magnifications: a, e, f, ×150; b, c, d, ×90). Journal of Hepatology 2004 41, 259-266DOI: (10.1016/j.jhep.2004.04.014)

Fig. 2 Continuous pattern of endothelial cell differentiation in hepatocellular adenoma CD31 (a) and CD34 (b) are readily expressed by the endothelial linings of both intra-tumoral arteries (large arrows) and intra-tumoral sinusoid vessels (long arrows). CD4 (c) and the receptor II for FcIgG (Cdw32) (d) are undetectable along intra-tumoral sinusoid vessels, whereas they are expressed by, respectively, scattered lymphocytes and macrophages (arrows). Laminin-1 (e) is present in the subendothelial matrix of intra-tumoral sinusoid vessels (long arrow), but is undetectable in the adjacent, non tumoral liver (NT). Tenascin (f) is undetectable along intra-tumoral sinusoid vessels (long arrows), whereas it is readily visible in the subendothelial matrix of an intra-tumoral artery (large arrow). (Frozen tissue sections; immunoperoxidase followed by Mayer's hematoxylin, original magnifications: a, b, e, ×90; c, d, f, ×150). Journal of Hepatology 2004 41, 259-266DOI: (10.1016/j.jhep.2004.04.014)

Fig. 3 Mixed pattern of endothelial cell differentiation in a case of hepatocellular adenoma At low magnification (a), this tumor is characterized by the coexistence of CD34+ vessels (long arrows) and CD34− vessels (∗) in adjacent territories. At higher magnification (b), the transition between CD34+ (long arrows) and CD34− (∗) territories is abrupt. (Formalin-fixed, paraffin-embedded tissue section; immunoperoxidase followed by Mayer's hematoxylin, original magnifications: a, ×60; b, ×130). Journal of Hepatology 2004 41, 259-266DOI: (10.1016/j.jhep.2004.04.014)